COLL Collegium Pharmaceutical Earnings and EPS analysis

EPS in 2026 (TTM): $2.36

Last Report Period Date: Mar 31, 2026

As of June this year, based on Collegium Pharmaceutical's most recent financial report, the company's trailing twelve months EPS is $2.36. During 2025, COLL reported a per-share earnings of $1.98, which shows a decline compared to the EPS of $2.14 recorded in 2024. Collegium Pharmaceutical's EPS for the quarterly period ending on Mar 31, 2026 came in at $0.45.

The yearly earnings per share during 2025 was $1.98, a decline of 7.5% compared to $2.14 recorded in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at $0.45, reflecting a 462.5% increase compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $2.36. During 2024, the annual earnings per share was $2.14, representing an increase of 49.7% compared to 2023.

Collegium Pharmaceutical has recorded a growth in earnings per share of 462.5% in the past 12 months (YoY, quarterly). Collegium Pharmaceutical had an average annual EPS growth of 20.5% in the last five years.